Navigation Links
Haptoglobin in Medical News

Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference

... damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment using haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...

Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

... damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment, using haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...

Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2

... glutathione peroxidase mimetic, in diabetic patients with a variant of haptoglobin that renders them at high risk for cardiovascular complications. ... development of diabetes 'on top of' a predisposing genetic factor called haptoglobin 2-2 (Hp2-2), which is found in 40% of the human population. The ...
Haptoglobin in Medical Technology

Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes

... enzyme immunoassay can determine a person's haptoglobin pheno/genotype in less than two hours, and can ... antibody that differentiates between the three haptoglobin pheno/genotypes. Blood samples from diabetic patients with known haptoglobin pheno/genotypes were tested using Synvista's ...

Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease

... Company to Continue Focus on Pipeline and haptoglobin Diagnostic Assay MONTVALE, N.J., June 6 ... 2 diabetic patients. Trial 201a established that haptoglobin (Hp) types, the target of Synvista's proprietary haptoglobin variant test currently under ...

Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions

... Results of Mouse Model of Diabetes with haptoglobin 2-2 Genotype Show Modification of HDL Structure ... data from a study of diabetic mice with the haptoglobin 2-2 genotype that show impairment in the clearance of the haptoglobin (Hp)-Hemoglobin (Hb) complex may result in a ...

Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing

... patients with Diabetes Mellitus (DM) who had the haptoglobin 2-2 (Hp2-2) phenotype met its pre-specified, ... study, more than 3,000 patients were tested for haptoglobin phenotype, and 984 of these who had the ... based on cardiovascular risk assessment, using haptoglobin characterization, to identify patients at high ...

Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes

... SYI ) announced results from a study demonstrating the important role of haptoglobin (Hp) typing in determining the risk of cardiovascular complications in ... a clinical diagnostic test, based on cardiovascular risk assessment, using haptoglobin characterization, to identify patients at high risk for cardiovascular ...

Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes

... development platform, including our work developing a diagnostic test for haptoglobin type, to determine cardiovascular risk and a therapeutic product to ... a clinical diagnostic test, based on cardiovascular risk assessment, using haptoglobin characterization, to identify patients at high risk for cardiovascular ...

Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis

... cardiovascular disease in people with diabetes. The Company has developed a clinical laboratory test that identifies diabetic patients with the haptoglobin genotype Hp2-2. The genetic or protein form of this test can be used to identify diabetic patients at high risk for cardiovascular complications. ...

Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure

... damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment, using haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...

Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications

... damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment, using haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...
Haptoglobin in Medical Dictionary

Haptoglobin

... haptoglobin Definition: This is a test that measures the amount of haptoglobin , a protein that binds free hemoglobin , in blood . haptoglobin A protein in blood plasma that binds ...

Hantavirus

... syndrome Causes, incidence , and risk factors: Text Continued Below ... Hantavirus Hantavirus Pulmonary Syndrome ( Hantavirus ) haptoglobin Hard Liquor Consumption ( Alcohol Use ) Hardening of the Arteries ( Atherosclerosis ) ... hantavirus pulmonary syndrome (HPS) Acute ...

LDH

... released into the blood stream in increased concentration when the heart muscle becomes damaged. Examples include SGOT, CPK-MB, and LDH . haptoglobin - The levels of this protein in the blood are low in people with hemolytic anemia . Lactate dehydrogenase ( LDH ) and bilirubin - Results of ...

Protein electrophoresis

... serum protein electrophoresis separates your blood protein s and can detect the presence of M protein s in the blood . Certain globulins ( haptoglobin s) bind with hemoglobin . Other globulins transport metals, such as iron, in the blood and help fight infection . Serum globulin can be ...
Haptoglobin in Biological Technology

Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting

... our clinical laboratory test which determines haptoglobin genotype may be useful in selecting and guiding ... capable of inflicting oxidative tissue damage. haptoglobin binds to this extracellular hemoglobin and ... by the liver or specialized white blood cells. haptoglobin in humans exists as three different proteins that ...

Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association

... Data Presented at the Meeting Report the Use of haptoglobin Typing to Predict Cardiovascular Risk, and ... Orleans, that a new clinical test to determine haptoglobin (Hp) genotype utilizing intellectual property ... patients with Hp2-2 Diabetes." At present, the haptoglobin genotype test is offered by ARUP Laboratories. A ...

Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales

... our first commercialization program for our haptoglobin diagnostic," said Noah Berkowitz, M.D., ... University. About Haptoglobin The polymorphic haptoglobin (Hp) protein is derived from two alleles, 1 and ... it has been established that the haptoglobin genotype is an independent risk factor for ...

Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes

... Cardiovascular Events in Diabetics with haptoglobin 2-2 Genotype ... who tested positive for a genetic marker called haptoglobin 2-2 (Hp2-2). This sub-analysis was published ... is developing a diagnostic product to identify haptoglobin types. "This study demonstrates that positive ...

Synvista Therapeutics Posts Letter to Stockholders on Web Site

... on which we are building our business. We have: -- Advanced our haptoglobin (Hp) diagnostic test. -- Developed a test for Carboxy-methyl-lysine ... 21, demonstrated that in patients with Diabetes Mellitus (DM) who had the haptoglobin 2-2 (Hp2-2) genotype, supplementation with Vitamin E therapy decreased ...

Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

... held November 10th - 12th at the New York Palace Hotel in New York City. Dr. Berkowitz will discuss the company's planned commercialization of its haptoglobin test kit for diabetes and ongoing Phase 2 initiatives for alagebrium in heart failure. He will also provide an update of recent milestones. The ...

Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference

... for SYI-2074 (formerly ALT-2074) in cardiovascular diseases, alagebrium in heart failure and diabetic nephropathy and progress on the company's haptoglobin diagnostic test. He will also provide an update of recent milestones and executive appointments. The presentation will be simultaneously webcast ...

Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference

... damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment using haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...

Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis

... damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment using haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...

Synvista Therapeutics to be Featured on Wallst.net

... damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment, using haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...
Haptoglobin in Biological Products

Goat Anti-Human Haptoglobin Polyclonal Antibody, Unconjugated from Abcam

Description:... Goat polyclonal to haptoglobin ( Abpromise for all tested applications). Antigen: Affinity purified human haptoglobin. Entrez GeneID: 3240 Swiss Protein ID: ...
Company:Abcam

Multiple Affinity Removal System from Agilent Technologies

Description:... one device. With this revolutionary system, you can: Remove six targeted, high-abundant proteins: albumin, lgG, antitrypsin, lgA, transferrin and haptoglobin (representing 85-90% of total serum protein mass) Improve the results you get with protein separation methods such as 1DGE, 2DGE and MD-HPLC Go ...
Company:Agilent Technologies
Other Contents
(Date:8/27/2014)... New York (PRWEB) August 27, 2014 ... by Transparency Market Research "Ablation Technologies Market (Applications: ... Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global ... 2014 - 2020," the global ablation technologies market ... and is estimated to reach a market worth ...
(Date:8/27/2014)... new analysis of clinical trial participation in the largest ... found participants are not representative of the larger patient ... Hospital cardiologist Dr. Jay Udell. The study authors call ... the wider population, and suggest the use of broader ... participation. , "We know that clinical trials can be ...
(Date:8/27/2014)... the onset of a cancer defense mechanism known ... Cancer Center are leveraging it in a new ... cell death rather than survival. The novel treatment ... referred to as the "Trash Man" due to ... autophagy. Results from preclinical experiments suggest this experimental ...
(Date:8/27/2014)... Disability (CLD) has received a two-year, $600,000 grant ... the Health Resources and Services Administration to support ... at improving services for children and youth with ... project, CLD worked with an Autism Advisory Council ... resulting plan addresses priorities of increased awareness of ...
(Date:8/27/2014)... (Lebanon, NH 8/27/14)Dartmouth cancer researchers developed and tested ... and environmental interactions that contribute to disease as ... , The approach fills a gap in ... from complex interactions among genetic and environmental factors. ... relevant interactions versus those that reflect chance combinations ...
Breaking Medicine News(10 mins):Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 3Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 4Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 5Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2Health News:Dartmouth isolates environmental influences in genome-wide association studies 2
(Date:8/27/2014)... /PRNewswire-iReach/ -- The IEEE Engineering in Medicine and Biology ... International Conference (EMBC,14), this year being held at the ... Illinois , from Tuesday, August 26 through Saturday, ... industry professionals in science, medicine, and engineering are registered ... This year,s conference theme is ...
(Date:8/27/2014)... as giant, frightening beasts. But every creature is a ... slab containing fossils of 24 very young dinosaurs and ... hatchlings overseen by a caretaker, according to a new ... P. Hedrick and Peter Dodson led the work, collaborating ... where the specimen is held. Hedrick is a doctoral ...
(Date:8/27/2014)... is available in German . ... the most common inherited disease affecting the peripheral nervous ... Max Planck Institute of Experimental Medicine and University Medical ... cells is impaired in rats with the disease. These ... known as myelin, which facilitates the rapid transfer of ...
Breaking Biology News(10 mins):Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 3Potential therapy for incurable Charcot-Marie-Tooth disease 2
Other TagsOther Tags